4 Result(s)
within
Ying-jie Xu
Oncology
-
Article
Open AccessFractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma
To evaluate the efficacy and toxicity of fractionated stereotactic radiotherapy (FSRT) in patients with residual nasopharyngeal carcinoma (NPC).
-
Article
Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis
In the past, some small peptide ligands identified by phage display technologies have successfully been used in early cancer diagnostics and therapy. In the present study, a novel CD59-binding peptide was iden...
-
Article
Open AccessHypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
To evaluate the efficacy and outcomes of hypofractionated stereotactic radiotherapy (HSRT) for brain metastases > 3 cm.
-
Article
Open AccessRisk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone
To explore the risk factors of distant brain failure (DBF) for patients with brain metastasis (BM) who were treated with stereotactic radiotherapy alone and to group the patients on the basis of their risk lev...
